GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioceltix BCX.WA · PLN

Health Care · GPW · 🇵🇱 Poland

Compare

68.70

-0.43%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in PLN, from our data supplier.

FY2025

Revenue

—

FY2018FY2025

Net income

−PLN 15.2m

FY2018FY2025

Free cash flow

−PLN 14.1m

FY2018FY2025

Shareholders' equity

PLN 73.3m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue—————PLN 10,800PLN 1,500PLN 9,202
Gross profit−PLN 680,062−PLN 574,435−PLN 1.0m−PLN 445,385−PLN 376,978−PLN 3.9m−PLN 3.5m−PLN 1.8m
Research and developmentPLN 3.5mPLN 6.4mPLN 3.8mPLN 1.3mPLN 1.9m———
Operating income−PLN 17.3m−PLN 18.8m−PLN 15.8m−PLN 9.7m−PLN 6.2m−PLN 4.0m−PLN 3.8m−PLN 1.9m
Net income−PLN 15.2m−PLN 14.9m−PLN 13.7m−PLN 8.9m−PLN 4.4m−PLN 2.3m−PLN 1.6m−PLN 775,690
Diluted earnings per share-2.87-3.03-3.31-2.60-1.34-0.42-0.29-0.14

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsPLN 75.6mPLN 41.9mPLN 12.7mPLN 6.0mPLN 8.2mPLN 4.8mPLN 3.2mPLN 3.3m
Cash and short-term investmentsPLN 68.4mPLN 33.6mPLN 9.3mPLN 4.1mPLN 6.1mPLN 3.2mPLN 1.1mPLN 1.6m
Total liabilitiesPLN 2.4mPLN 3.4mPLN 2.3mPLN 2.5mPLN 2.2mPLN 1.5mPLN 1.3mPLN 1.7m
DebtPLN 314,902PLN 823,920PLN 175,057PLN 293,942PLN 530,830PLN 104,165PLN 165,000—
Shareholders' equityPLN 73.3mPLN 38.4mPLN 10.5mPLN 5.2mPLN 6.0mPLN 3.3mPLN 1.9mPLN 1.6m
Shares outstanding5m5m4m3m3m6m6m6m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−PLN 12.1m−PLN 17.7m−PLN 14.7m−PLN 7.9m−PLN 4.0m−PLN 1.5m−PLN 1.7m−PLN 1.8m
Capital spending−PLN 2.0m−PLN 242,780−PLN 458,352−PLN 351,734−PLN 5,984−PLN 13,909−PLN 179,667−PLN 523,195
Free cash flow−PLN 14.1m−PLN 18.0m−PLN 15.2m−PLN 8.3m−PLN 4.0m−PLN 1.5m−PLN 1.8m−PLN 2.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Gross profit−PLN 192,243−PLN 161,647−PLN 161,626−PLN 160,783−PLN 501,092−PLN 472,100−PLN 209,257−PLN 426,261
Operating income−PLN 5.5m−PLN 6.1m−PLN 4.7m−PLN 4.4m−PLN 3.7m−PLN 3.8m−PLN 4.7m−PLN 3.5m
Net income−PLN 5.1m−PLN 5.7m−PLN 3.4m−PLN 4.4m−PLN 3.7m−PLN 3.8m−PLN 3.0m−PLN 3.5m
Diluted earnings per share-0.92-1.03-0.64-0.83-0.71-0.72-0.61-0.70
Cash from operations−PLN 2.0m−PLN 6.0m−PLN 4.0m−PLN 5.0m−PLN 1.0m—−PLN 4.0m−PLN 6.0m
Capital spending−PLN 1.0m−PLN 1.0m——————
Free cash flow−PLN 3.0m−PLN 7.0m——————
Total assetsPLN 65.7mPLN 70.6mPLN 75.6mPLN 30.2mPLN 34.9mPLN 39.3mPLN 41.9mPLN 44.4m
Cash and short-term investmentsPLN 56.8mPLN 60.8mPLN 68.4mPLN 24.0mPLN 30.0mPLN 32.6mPLN 33.6mPLN 38.2m
DebtPLN 129,255PLN 170,808PLN 227,328PLN 291,722PLN 316,553PLN 494,314PLN 1.3mPLN 777,154
Shareholders' equityPLN 62.5mPLN 67.6mPLN 73.3mPLN 27.0mPLN 31.4mPLN 34.6mPLN 38.4mPLN 41.4m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income21.4%34.1%—
Net income19.3%45.2%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-27.0-29.0-27.1-14.9-39.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.